Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1172 | 991 | 1172 | 950 | 1723 | - |
Fund Return | 17.17% | -0.93% | 17.17% | -1.69% | 11.49% | - |
Place in category | 794 | 1024 | 794 | 1726 | 211 | - |
% in Category | 30 | 37 | 30 | 72 | 14 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
PG S Listed Infrastructure USD I Ac | 484.97M | -3.27 | -1.83 | 3.39 | ||
PG S Listed Private Equity USD P Ac | 420.9M | 22.59 | 5.12 | 12.20 | ||
Rezco Glbl Flxbl Fund A USD | 53.52M | -0.91 | 2.32 | - | ||
LU0803005494 | 45.88M | 2.32 | 2.09 | 0.61 | ||
PPF CP Global BioPharma Fund I USD | 16.59M | -5.37 | -12.83 | -1.10 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Cap Group New Perspective lux ZLgd | 16.41B | 18.28 | 3.62 | 10.80 | ||
Cap Group New Perspective lux C | 16.41B | 17.04 | 2.93 | - | ||
Cap Group New Perspective lux ZL | 16.41B | 16.33 | 2.33 | 10.85 | ||
Cap Group New Perspective lux A7 | 16.41B | 16.51 | 2.48 | - | ||
Cap Group New Perspective lux ZLd | 16.41B | 16.42 | 2.36 | 10.86 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Xylem | US98419M1009 | 3.09 | 121.25 | -0.07% | |
ASML Holding | NL0010273215 | 3.02 | 682.50 | +5.55% | |
Intuit | US4612021034 | 3.02 | 592.99 | -1.28% | |
Eli Lilly | US5324571083 | 2.96 | 804.08 | -0.11% | |
Palo Alto Networks | US6974351057 | 2.93 | 185.42 | -3.90% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review